IFN γ released from immunotherapy-actived CD8+ T promotes ferroptosis in tumor cells by decreasing the expression of SLC3A2 and SLC7A11, which is instrumental in boosting the efficacy of cancer immunotherapy (Wang et al., 2019). The gene discussed is SLC3A2; the disease is cancer.